Nekić, J.; Stanković Matić, I.; Rački, V.; Janko Labinac, D.; Vuletić, V.; Kapović, M.; Ristić, S.; Peterlin, B.; Starčević Čizmarević, N.
CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients. Int. J. Mol. Sci. 2024, 25, 7412.
https://doi.org/10.3390/ijms25137412
AMA Style
Nekić J, Stanković Matić I, Rački V, Janko Labinac D, Vuletić V, Kapović M, Ristić S, Peterlin B, Starčević Čizmarević N.
CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients. International Journal of Molecular Sciences. 2024; 25(13):7412.
https://doi.org/10.3390/ijms25137412
Chicago/Turabian Style
Nekić, Jasna, Ivana Stanković Matić, Valentino Rački, Dolores Janko Labinac, Vladimira Vuletić, Miljenko Kapović, Smiljana Ristić, Borut Peterlin, and Nada Starčević Čizmarević.
2024. "CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients" International Journal of Molecular Sciences 25, no. 13: 7412.
https://doi.org/10.3390/ijms25137412
APA Style
Nekić, J., Stanković Matić, I., Rački, V., Janko Labinac, D., Vuletić, V., Kapović, M., Ristić, S., Peterlin, B., & Starčević Čizmarević, N.
(2024). CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients. International Journal of Molecular Sciences, 25(13), 7412.
https://doi.org/10.3390/ijms25137412
